4//SEC Filing
Gourlay Steve 4
Accession 0001209191-18-051831
CIK 0001510487other
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 6:47 PM ET
Size
8.5 KB
Accession
0001209191-18-051831
Insider Transaction Report
Form 4
Gourlay Steve
Chief Medical Officer
Transactions
- Conversion
Series B-3 Preferred Stock
2018-09-18−7,269→ 0 total→ Common Stock (7,269 underlying) - Conversion
Common Stock
2018-09-18+7,269→ 107,857 total
Holdings
- 625
Warrant (Right to Buy)
Exp: 2022-12-29→ Common Stock (625 underlying)
Footnotes (3)
- [F1]Each share of Preferred Stock automatically converted into one (1) share of Common Stock, for no additional consideration, upon the consummation of the Issuer's initial public offering.
- [F2]This warrant has converted from a warrant to purchase Series B-3 Preferred Stock into a warrant to purchase Common Stock.
- [F3]This warrant is exercisable at any time.
Documents
Issuer
Principia Biopharma Inc.
CIK 0001510487
Entity typeother
Related Parties
1- filerCIK 0001751884
Filing Metadata
- Form type
- 4
- Filed
- Sep 19, 8:00 PM ET
- Accepted
- Sep 20, 6:47 PM ET
- Size
- 8.5 KB